Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
9.17
-0.10 (-1.08%)
At close: Dec 12, 2025
-36.32%
Market Cap14.82B
Revenue (ttm)3.76B
Net Income (ttm)649.83M
Shares Out1.62B
EPS (ttm)0.40
PE Ratio22.82
Forward PE15.03
Dividend0.10 (1.09%)
Ex-Dividend DateJun 5, 2025
Volume13,019,270
Average Volume10,730,929
Open9.25
Previous Close9.27
Day's Range9.10 - 9.27
52-Week Range9.10 - 14.86
Beta0.65
RSI21.82
Earnings DateApr 27, 2026

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chloride, reganosin, isoflurane blue, clofarabine, haloperidol d... [Read more]

Sector Healthcare
Founded 2000
Employees 1,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.